Final Notes Proper storage of peptides is crucial for maintaining their efficacy and reliability in research applications
Specific medical applications: Studies are ongoing to explore the potential use of BPC-157 in the treatment or management of various medical conditions, such as skin ulcers, gastrointestinal disorders, inflammatory conditions, and neurological disorders
Subcutaneous administration is most common, with rotation between: Abdominal area Thigh regions Upper arm Gluteal area Some users prefer localized injection near injury sites, which may influence timing based on activity schedules
Typical protocol: 300mcg AOD-9604 fasted AM + 500mcg1mg MOTS-C 35x per week (SubQ or IV, depending on access) AOD-9604 + Tesamorelin Tesamorelin is a GHRH analog approved (as Egrifta) for HIV-associated lipodystrophy specifically visceral fat reduction
The success of GLP-1 agonists in clinical practice has validated the concept that pharmacological approaches to obesity are effective but it has also highlighted their limitations
